Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Entrada Therapeutics, Inc.(TRDA) | 4,408,379 | 4,408,379 | 0 | $76.22M | $39.85M | 15.07% | -$36.37M |
| Enliven Therapeutics Inc | 1,629,765 | 1,322,477 | -307,288 | $36.67M | $26.03M | 9.84% | -$10.64M |
| Dianthus Therapeutics, Inc.(DNTH) | 1,027,711 | 1,027,711 | 0 | $22.40M | $18.64M | 7.05% | -$3.76M |
| Skye Bioscience, Inc.(SKYE) | 9,913,168 | 9,913,168 | 0 | $28.05M | $15.76M | 5.96% | -$12.29M |
| Pharvaris N V COM | 797,600 | 797,600 | 0 | $15.29M | $12.52M | 4.74% | -$2.77M |
| Centessa Pharmaceuticals PlcADS | 830,945 | 830,945 | 0 | $13.92M | $11.95M | 4.52% | -$1.97M |
| CAMP4 THERAPEUTICS CORPORATION(CAMP) | 2,927,915 | 2,927,915 | 0 | $15.28M | $11.71M | 4.43% | -$3.57M |
| Biohaven Ltd.(BHVN) | 478,972 | 478,972 | 0 | $17.89M | $11.51M | 4.35% | -$6.38M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 282,313 | 282,313 | 0 | $15.29M | $11.03M | 4.17% | -$4.26M |
| Viridian Therapeutics, Inc.(VRDN) | 736,595 | 736,595 | 0 | $14.12M | $9.93M | 3.76% | -$4.19M |
| Tectonic Therapeutic, Inc.(TECX) | 596,660 | 511,660 | -85,000 | $27.55M | $9.06M | 3.43% | -$18.49M |
| Celldex Therapeutics, Inc.(CLDX) | 497,270 | 497,270 | 0 | $12.57M | $9.03M | 3.41% | -$3.54M |
| Tyra Biosciences, Inc.(TYRA) | 939,298 | 939,298 | 0 | $13.06M | $8.74M | 3.30% | -$4.32M |
| Erasca, Inc.(ERAS) | 5,405,404 | 5,405,404 | 0 | $13.57M | $7.41M | 2.80% | -$6.16M |
| Artiva Biotherapeutics, Inc.(ARTV) | 2,353,304 | 2,353,304 | 0 | $23.72M | $7.06M | 2.67% | -$16.66M |
| Anaptysbio Inc | 357,733 | 357,733 | 0 | $4.74M | $6.65M | 2.52% | +$1.91M |
| Praxis Precision Medicines, Inc.(PRAX) | 170,000 | 170,000 | 0 | $13.08M | $6.44M | 2.43% | -$6.65M |
| GH Research PLC(GHRS) | 572,665 | 572,665 | 0 | $4.01M | $6.32M | 2.39% | +$2.31M |
| EyePoint, Inc.(EYPT) | 1,050,000 | 1,050,000 | 0 | $7.82M | $5.69M | 2.15% | -$2.13M |
| Viking Therapeutics, Inc.(VKTX) | 189,593 | 189,593 | 0 | $7.63M | $4.58M | 1.73% | -$3.05M |
| Vor Biopharma Inc.(VOR) | 6,361,723 | 6,361,723 | 0 | $7.06M | $4.56M | 1.73% | -$2.50M |
| Surrozen, Inc.(SRZN) | 0 | 310,000 | +310,000 | $0 | $3.61M | 1.37% | +$3.61M |
| Protara Therapeutics, Inc.(TARA) | 800,000 | 800,000 | 0 | $4.22M | $3.41M | 1.29% | -$816.0K |
| Scpharmaceuticals Inc | 1,200,647 | 1,200,647 | 0 | $4.25M | $3.16M | 1.19% | -$1.09M |
| Rallybio Corporation(RLYB) | 3,630,724 | 3,630,724 | 0 | $3.49M | $2.38M | 0.90% | -$1.11M |
| Adverum Biotechnologies Inc | 541,666 | 541,666 | 0 | $2.53M | $2.37M | 0.90% | -$162.5K |
| Silence Therapeutics plcADS(SLN) | 476,200 | 476,200 | 0 | $3.28M | $1.34M | 0.51% | -$1.93M |
| Alector Inc | 995,841 | 995,841 | 0 | $1.88M | $1.22M | 0.46% | -$657.3K |
| Cidara Therapeutics Inc | 56,725 | 56,725 | 0 | $1.52M | $1.22M | 0.46% | -$302.9K |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 490,000 | 490,000 | 0 | $1.48M | $779.1K | 0.29% | -$705.6K |
| Mersana Therapeutics Inc | 1,305,000 | 1,305,000 | 0 | $1.87M | $449.2K | 0.17% | -$1.42M |
| Akero Therapeutics Inc | 165,000 | 0 | -165,000 | $4.59M | $0 | — | -$4.59M |